Osteoporosis quality indicators using healthcare utilization data

Osteoporosis International

Volumn 22, Issue 5, 2011, Pages 1335-1342

  Cadarette, S M ^a,b   Jaglal, S B ^a,b   Raman Wilms, L ^a   Beaton, D E ^a,c   Paterson, J M ^a,b,d,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e CENTRE FOR EVALUATION OF MEDICINES   (Canada)

Author keywords

Agreement; Bone density; Diagnosis; Osteoporosis; Sensitivity and specificity

Indexed keywords

ALENDRONIC ACID; ANTITHYROID AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; ESTROGEN; ETIDRONIC ACID; GLUCOCORTICOID; RALOXIFENE; RISEDRONIC ACID; STEROID;

AGED; ARTICLE; BONE DENSITY; CAUCASIAN; COMMUNITY; DRUG FORMULATION; DRUG UTILIZATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; PHARMACY; POSTMENOPAUSE OSTEOPOROSIS; PRESCRIPTION; PRIORITY JOURNAL; SCORING SYSTEM; SELF REPORT; SENSITIVITY AND SPECIFICITY; STEROID THERAPY; STRUCTURED INTERVIEW; TELEPHONE;

ABSORPTIOMETRY, PHOTON; AGED; AGED, 80 AND OVER; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; DRUG UTILIZATION; FEMALE; HUMANS; ONTARIO; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPOROTIC FRACTURES; QUALITY INDICATORS, HEALTH CARE; RISK FACTORS; SELF DISCLOSURE; SENSITIVITY AND SPECIFICITY;

EID: 79955474562     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-010-1329-8     Document Type: Article

References (20)

1. SL Sampsel CH MacLean LG Pawlson, et al. 2007 Methods to develop arthritis and osteoporosis measures: a view from the National Committee for Quality Assurance (NCQA) Clin Exp Rheumatol 25 Suppl 47 22 27 18021503 1:STN:280:DC%2BD2sjgsVKnsA%3D%3D
2. National Committee for Quality Assurance. Available at: http://www.ncqa.org/tabid/1044/Default.aspx. Accessed on 25 Aug 2009
3. SE Ward JJ Laughren BG Escott, et al. 2007 A program with a dedicated coordinator improved chart documentation of osteoporosis after fragility fracture Osteoporos Int 18 1127 1136 17333450 10.1007/s00198-007-0341-0 1:STN:280:DC%2BD2svmtlWqug%3D%3D (Pubitemid 47019999)
4. B Sander V Elliot-Gibson DE Beaton, et al. 2008 A coordinator program in post-fracture osteoporosis management improves outcomes and saves costs J Bone Joint Surg Am 90 1197 1205 18519311 10.2106/JBJS.G.00980 (Pubitemid 351778125)
5. SM Cadarette DE Beaton MAM Gignac, et al. 2007 Minimal error in self-report of having had DXA, but self-report of its results was poor J Clin Epidemiol 60 1306 1311 17998086 10.1016/j.jclinepi.2007.02.010 (Pubitemid 350064598)
6. SM Cadarette L Dickson MAM Gignac, et al. 2007 Predictors of locating women six to eight years after contact: internet resources at recruitment may help to improve response rates in longitudinal research BMC Med Res Methodol 7 22 17577404 10.1186/1471-2288-7-22 (Pubitemid 47030144)
7. SM Cadarette MAM Gignac DE Beaton, et al. 2007 Psychometric properties of the "Osteoporosis and you" questionnaire: osteoporosis knowledge deficits among older community-dwelling women Osteoporos Int 18 981 989 17333452 10.1007/s00198-007-0326-z 1:STN:280:DC%2BD2svivFaisQ%3D%3D (Pubitemid 46889555)
8. SM Cadarette MAM Gignac SB Jaglal, et al. 2007 Access to osteoporosis treatment is critically linked to access to dual-energy x-ray absorptiometry testing Med Care 45 896 901 17712261 10.1097/MLR.0b013e318054689f
9. SM Cadarette MAM Gignac SB Jaglal, et al. 2009 Measuring patient perceptions about osteoporosis pharmacotherapy BMC Res Notes 2 133 19602268 10.1186/1756-0500-2-133
10. SM Cadarette SB Jaglal GA Hawker 2005 Fracture prevalence and treatment with bone-sparing agents: are there urban-rural differences? A population based study in Ontario, Canada J Rheumatol 32 550 558 15742452 (Pubitemid 40381431)
11. World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organization, Geneva
12. Ontario Ministry of Health (1998) Revision to the schedule of facility fees: bone mineral analysis. Queen's Printer, Ontario
13. Ministry of Health and Long-Term Care (2008) Ontario drug benefit formulary/comparative drug index. Ministry of Health, Queen's Printer, Ontario
14. JR Curtis AO Westfall J Allison, et al. 2006 Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users Pharmacoepidemiol Drug Saf 15 710 718 16498575 10.1002/pds.1226 (Pubitemid 44649509)
15. MA Jaro 1995 Probabilistic linkage of large public health data files Stat Med 14 491 498 7792443 10.1002/sim.4780140510 1:STN:280:DyaK2Mzht1OjtQ%3D%3D
16. T Byrt 1996 How good is that agreement? Epidemiol 7 561 1:STN:280:DyaK2s%2Fhs1elsQ%3D%3D
17. A Kmetic L Joseph C Berger, et al. 2002 Multiple imputation to account for missing data in a survey: estimating the prevalence of osteoporosis Epidemiol 13 437 444 10.1097/00001648-200207000-00012 (Pubitemid 34627843)
18. AC Looker CC Johnston HW Wahner, et al. 1995 Prevalence of low femoral bone density in older U.S. women from NHANES III J Bone Miner Res 10 796 802 7639115 10.1002/jbmr.5650100517 1:STN:280:DyaK2Mzms1egtQ%3D%3D
19. LJ Melton 3rd 1995 How many women have osteoporosis now? J Bone Miner Res 10 175 177 7754796 10.1002/jbmr.5650100202
20. LM Lix MS Yogendran WD Leslie, et al. 2008 Using multiple data features improved the validity of osteoporosis case ascertainment from administrative databases J Clin Epidemiol 61 1250 1260 18619800 10.1016/j.jclinepi.2008.02.002